We are a coalition of doctors, researchers, patients, and entrepreneurs pioneering a new approach to curing diseases through innovative outcome-based financing. We collaborate with impact investors and payers to discover life-altering therapies and bring them to patients.

The first disease we are attacking is pancreatitis. The world’s top pancreatic experts believe a well-funded, coordinated research and development program could lead to effective treatments within 10 years. Mission: Cure is working to make that happen. Consulting with pancreatic experts from the nation’s top research and healthcare institutions, we developed a 10-year plan and are working to implement it.

OUR APPROACH

Financing Based On Patient Outcomes

a male scientist holds a pipette and puts liquid into small containers surroudned by beakers in a lab

Promising And Cost-Effective Methods To Cure Diseases

five business people sit around a laptop engaged in conversation

Active Collaboration Among Stakeholders

two people point and review a paper with bar and pie graphs

Partnerships With Impact Investors

The time is right to create a new model for curing disease.  Exciting developments in genetics and data are making precision medicine a reality. Healthcare payers are moving toward value-based funding, especially for chronic diseases.  And a new generation of impact investors—seeking to generate social and not just financial returns—have made curing disease a priority.

DONATE

We cannot do this without your support.

Donate

News from Mission: Cure

September 6, 2019 in News, Pain Management, Patient Resources, Webinars, Webinars: Pain Management

Pancreatitis and Chronic Pain: How Can I Manage?

On this Mission: Cure webinar, Dr. Tonya Palermo discusses pain self-management techniques If you or a family member have chronic pain from pancreatitis, Mission: Cure’s webinar with Dr. Tonya Palermo will be helpful as it explores the impact of chronic pain on children, adults and families dealing with pancreatitis. “Chronic Pain and Pancreatitis” was selected as the topic for this…
Read More
September 5, 2019 in Clinical Trials, Genetics, News, Patient Stories, Repurposing Drugs

Mission: Cure Update: PancreasFest and Progress

PancreasFest 2019 unveiled promising scientific discoveries and exciting collaboration opportunities, and Mission: Cure was there! Mission: Cure's Team at PancreasFest 2019. Big thanks to our amazing interns from Brown University and Amy Jensen who shared her story of living undiagnosed with chronic pancreatitis. Yes, PancreasFest is the name of a scientific conference held annually in Pittsburgh, PA in July where…
Read More

Mission: Cure – Blog

March 25, 2019 in Blog, Exocrine Pancreatic Insufficiency, Patient Resources

EPI and Pancreatic Enzymes: Expert Doctor Answers Patient Questions

Dr. Steven Freedman of Beth Israel Deaconess Medical Center and Harvard Medical School Dr. Steven Freedman, MD, Ph.D., a worldwide expert on pancreatic disease and cystic fibrosis, presented on Mission: Cure’s Pancreatitis Patient Webinar on Exocrine Pancreatic Insufficiency (EPI) and Pancreatic Enzyme Replacement Therapy (PERT). EPI is one of the symptoms of pancreatitis. Pancreatic enzymes are a confusing but critically…
Read More
January 11, 2019 in Blog, Genetics, Patient Resources, Topics

Genetic Testing for Pancreatitis: What We Know Now

Dr. Mark Haupt, MD is the Chief Medical Officer of Ariel Precision Medicine, a company that provides digital health and genomics solutions for complex disorders, like pancreatitis. Dr. Haupt is a Pediatric Pulmonologist who has dedicated his career to helping patients with pancreatic disease through his work in academia, the pharmaceutical industry, and his current work with Ariel. As a…
Read More

Mission: Cure – Twitter